Correlation Between Protagonist Therapeutics and Terns Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Protagonist Therapeutics and Terns Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Protagonist Therapeutics and Terns Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Protagonist Therapeutics and Terns Pharmaceuticals, you can compare the effects of market volatilities on Protagonist Therapeutics and Terns Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Protagonist Therapeutics with a short position of Terns Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Protagonist Therapeutics and Terns Pharmaceuticals.
Diversification Opportunities for Protagonist Therapeutics and Terns Pharmaceuticals
0.23 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Protagonist and Terns is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Protagonist Therapeutics and Terns Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Terns Pharmaceuticals and Protagonist Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Protagonist Therapeutics are associated (or correlated) with Terns Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Terns Pharmaceuticals has no effect on the direction of Protagonist Therapeutics i.e., Protagonist Therapeutics and Terns Pharmaceuticals go up and down completely randomly.
Pair Corralation between Protagonist Therapeutics and Terns Pharmaceuticals
Given the investment horizon of 90 days Protagonist Therapeutics is expected to generate 1.01 times more return on investment than Terns Pharmaceuticals. However, Protagonist Therapeutics is 1.01 times more volatile than Terns Pharmaceuticals. It trades about -0.07 of its potential returns per unit of risk. Terns Pharmaceuticals is currently generating about -0.08 per unit of risk. If you would invest 4,843 in Protagonist Therapeutics on August 30, 2024 and sell it today you would lose (348.00) from holding Protagonist Therapeutics or give up 7.19% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 95.65% |
| Values | Daily Returns |
Protagonist Therapeutics vs. Terns Pharmaceuticals
Performance |
| Timeline |
| Protagonist Therapeutics |
| Terns Pharmaceuticals |
Protagonist Therapeutics and Terns Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Protagonist Therapeutics and Terns Pharmaceuticals
The main advantage of trading using opposite Protagonist Therapeutics and Terns Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Protagonist Therapeutics position performs unexpectedly, Terns Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Terns Pharmaceuticals will offset losses from the drop in Terns Pharmaceuticals' long position.| Protagonist Therapeutics vs. Revolution Medicines | Protagonist Therapeutics vs. Akero Therapeutics | Protagonist Therapeutics vs. Avidity Biosciences | Protagonist Therapeutics vs. Stoke Therapeutics |
| Terns Pharmaceuticals vs. Amylyx Pharmaceuticals | Terns Pharmaceuticals vs. Acumen Pharmaceuticals | Terns Pharmaceuticals vs. Inozyme Pharma | Terns Pharmaceuticals vs. X4 Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |